{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:59:28Z","timestamp":1767153568529,"version":"build-2238731810"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-82656-5","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:23:41Z","timestamp":1759173821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-step organic synthesis, cytotoxicity, and molecular docking of new N-phenylpyrazolones incorporated with N-benzylthiazole or N-benzyl-4-thiazolone fragments"],"prefix":"10.1038","volume":"15","author":[{"given":"Abdullah A.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud M. Abd","family":"El-All","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salwa M.","family":"El-Hallouty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab A.","family":"Elshahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-1427","authenticated-orcid":false,"given":"Essam M.","family":"Eliwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"82656_CR1","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1038\/s41467-023-40575-5","volume":"14","author":"L Hudson","year":"2023","unstructured":"Hudson, L. et al. Diversity-oriented synthesis encoded by deoxyoligonucleotides. Nat. Commun. 14, 4930 (2023).","journal-title":"Nat. Commun."},{"key":"82656_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/tcr.20144","volume":"8","author":"RJ Spandl","year":"2008","unstructured":"Spandl, R. J., D\u00edaz-Gavil\u00e1n, M., O\u2019Connell, K. M. G., Thomas, G. L. & Spring, D. R. Diversity-oriented synthesis. Chem. Rec. 8, 129\u2013142 (2008).","journal-title":"Chem. Rec"},{"key":"82656_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/ncomms1081","volume":"1","author":"WRJD Galloway","year":"2010","unstructured":"Galloway, W. R. J. D., Isidro-Llobet, A. & Spring, D. R. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nat. Commun. 1, 80 (2010).","journal-title":"Nat. Commun."},{"key":"82656_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3389\/fchem.2018.00522","volume":"6","author":"E Lenci","year":"2018","unstructured":"Lenci, E., Innocenti, R., Menchi, G. & Trabocchi, A. Diversity-oriented synthesis and chemoinformatic analysis of the Molecular Diversity of sp3-Rich Morpholine Peptidomimetics. Front. Chem. 6, 522 (2018).","journal-title":"Front. Chem."},{"key":"82656_CR5","doi-asserted-by":"crossref","unstructured":"Phiri, C. M. & Saxena, A. Multi-step organic synthesis: A review of some synthetic routes and applications. AIP Conf. Proc. 2535, 040007 (2023).","DOI":"10.1063\/5.0116182"},{"key":"82656_CR6","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1021\/acs.jchemed.2c00508","volume":"99","author":"MF Mechelke","year":"2022","unstructured":"Mechelke, M. F. Advanced Organic Chemistry Laboratory: a Multistep synthesis toward the Preparation of a small Library of Antituberculosis compounds. J. Chem. Educ. 99, 3265\u20133271 (2022).","journal-title":"J. Chem. Educ."},{"key":"82656_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2174\/138527212799499921","volume":"16","author":"S Hamama","year":"2012","unstructured":"Hamama, S., El-Gohary, W. G., Kuhnert, H., Zoorob, H. & N. & Chemistry of Pyrazolinones and their applications. Curr. Org. Chem. 16, 373\u2013399 (2012).","journal-title":"Curr. Org. Chem."},{"key":"82656_CR8","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/jhet.4858","volume":"61","author":"AA Ahmed","year":"2024","unstructured":"Ahmed, A. A., El-All, M. M. A., El\u2010Hallouty, S. M., Elshahid, Z. A. & Eliwa, E. M. New edaravone analogs incorporated with N \u2010benzylthiazole moiety: multistep chemical synthesis, in vitro cytotoxicity with pRIPK3 inhibitory activities, and molecular docking. J. Heterocycl. Chem. 61, 1349\u20131363 (2024).","journal-title":"J. Heterocycl. Chem."},{"key":"82656_CR9","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1021\/acs.orglett.0c01475","volume":"22","author":"Y Xu","year":"2020","unstructured":"Xu, Y., Shen, M., Zhang, X. & Fan, X. Selective synthesis of Pyrazolo[1,2- a ]pyrazolones and 2-Acylindoles via Rh(III)-Catalyzed tunable redox-neutral coupling of 1-Phenylpyrazolidinones with Alkynyl Cyclobutanols. Org. Lett. 22, 4697\u20134702 (2020).","journal-title":"Org. Lett."},{"key":"82656_CR10","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1002\/tcr.201800199","volume":"19","author":"X Xie","year":"2019","unstructured":"Xie, X., Xiang, L., Peng, C. & Han, B. Catalytic asymmetric synthesis of Spiropyrazolones and their application in Medicinal Chemistry. Chem. Rec. 19, 2209\u20132235 (2019).","journal-title":"Chem. Rec"},{"key":"82656_CR11","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.ccr.2007.02.010","volume":"251","author":"J Casas","year":"2007","unstructured":"Casas, J., Garcia-Tasende, M., Sanchez, A., Sordo, J. & Touceda, A. Coordination modes of 5-pyrazolones: a solid-state overview. Coord. Chem. Rev. 251, 1561\u20131589 (2007).","journal-title":"Coord. Chem. Rev."},{"key":"82656_CR12","doi-asserted-by":"publisher","first-page":"111893","DOI":"10.1016\/j.ejmech.2019.111893","volume":"186","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z. et al. Pyrazolone structural motif in medicinal chemistry: retrospect and prospect. Eur. J. Med. Chem. 186, 111893 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"82656_CR13","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1517\/14656566.2010.493558","volume":"11","author":"PA Lapchak","year":"2010","unstructured":"Lapchak, P. A. A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Expert Opin. Pharmacother. 11, 1753\u20131763 (2010).","journal-title":"Expert Opin. Pharmacother"},{"key":"82656_CR14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ejmech.2014.11.059","volume":"97","author":"\u015eG K\u00fc\u00e7\u00fckg\u00fczel","year":"2015","unstructured":"K\u00fc\u00e7\u00fckg\u00fczel, \u015e. G. & \u015eenkarde\u015f, S. Recent advances in bioactive pyrazoles. Eur. J. Med. Chem. 97, 786\u2013815 (2015).","journal-title":"Eur. J. Med. Chem."},{"key":"82656_CR15","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1093\/clinchem\/24.12.2161","volume":"24","author":"F Meiattini","year":"1978","unstructured":"Meiattini, F., Prencipe, L., Bardelli, F., Giannini, G. & Tarli, P. The 4-hydroxybenzoate\/4-aminophenazone chromogenic system used in the enzymic determination of serum cholesterol. Clin. Chem. 24, 2161\u20132165 (1978).","journal-title":"Clin. Chem."},{"key":"82656_CR16","doi-asserted-by":"publisher","first-page":"e0122918","DOI":"10.1371\/journal.pone.0122918","volume":"10","author":"T K\u00f6tter","year":"2015","unstructured":"K\u00f6tter, T. et al. Metamizole-Associated adverse events: a systematic review and Meta-analysis. PLoS One. 10, e0122918 (2015).","journal-title":"PLoS One"},{"key":"82656_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/j.seminhematol.2014.10.002","volume":"52","author":"R Desmond","year":"2015","unstructured":"Desmond, R., Townsley, D. M., Dunbar, C. & Young, N. S. Eltrombopag in Aplastic Anemia. Semin Hematol. 52, 31\u201337 (2015).","journal-title":"Semin Hematol."},{"key":"82656_CR18","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","volume":"376","author":"DM Townsley","year":"2017","unstructured":"Townsley, D. M. et al. Eltrombopag added to Standard Immunosuppression for aplastic Anemia. N Engl. J. Med. 376, 1540\u20131550 (2017).","journal-title":"N Engl. J. Med."},{"key":"82656_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ijcard.2010.05.038","volume":"148","author":"A Akyel","year":"2011","unstructured":"Akyel, A., Alsancak, Y., Yayla, \u00c7., \u015eahinarslan, A. & \u00d6zdemir, M. Acute inferior myocardial infarction with low atrial rhythm due to propyphenazone: Kounis syndrome. Int. J. Cardiol. 148, 352\u2013353 (2011).","journal-title":"Int. J. Cardiol."},{"key":"82656_CR20","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1136\/bmj.1.5397.1553","volume":"1","author":"FD Hart","year":"1964","unstructured":"Hart, F. D. & Boardman, P. L. Trial of Nifenazone (\u2018Thylin\u2019). BMJ 1, 1553\u20131554 (1964).","journal-title":"BMJ"},{"key":"82656_CR21","doi-asserted-by":"publisher","first-page":"101669","DOI":"10.1016\/j.jscs.2023.101669","volume":"27","author":"GRS Ashour","year":"2023","unstructured":"Ashour, G. R. S. et al. Synthesis, modeling, and biological studies of new thiazole-pyrazole analogues as anticancer agents. J. Saudi Chem. Soc. 27, 101669 (2023).","journal-title":"J. Saudi Chem. Soc."},{"key":"82656_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13065-023-00921-6","volume":"17","author":"ME Salem","year":"2023","unstructured":"Salem, M. E., Mahrous, E. M., Ragab, E. A., Nafie, M. S. & Dawood, K. M. Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR\/HER2 target inhibition. BMC Chem. 17, 51 (2023).","journal-title":"BMC Chem."},{"key":"82656_CR23","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.1021\/acsomega.2c08137","volume":"8","author":"Y Nandurkar","year":"2023","unstructured":"Nandurkar, Y., Shinde, A., Bhoye, M. R., Jagadale, S. & Mhaske, P. C. Synthesis and Biological Screening of New 2-(5-Aryl-1-phenyl-1 H -pyrazol-3-yl)-4-aryl thiazole derivatives as potential Antimicrobial agents. ACS Omega. 8, 8743\u20138754 (2023).","journal-title":"ACS Omega"},{"key":"82656_CR24","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.1021\/acsomega.2c06954","volume":"8","author":"NH Metwally","year":"2023","unstructured":"Metwally, N. H. & El-Desoky, E. A. Novel Thiopyrano[2,3- d ]thiazole-pyrazole hybrids as potential Nonsulfonamide Human Carbonic anhydrase IX and XII inhibitors: design, synthesis, and biochemical studies. ACS Omega. 8, 5571\u20135592 (2023).","journal-title":"ACS Omega"},{"key":"82656_CR25","doi-asserted-by":"publisher","first-page":"103898","DOI":"10.1016\/j.arabjc.2022.103898","volume":"15","author":"S Abu-Melha","year":"2022","unstructured":"Abu-Melha, S. Molecular modeling and docking studies of new antimicrobial antipyrine-thiazole hybrids. Arab. J. Chem. 15, 103898 (2022).","journal-title":"Arab. J. Chem."},{"key":"82656_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tips.2020.01.002","volume":"41","author":"S Martens","year":"2020","unstructured":"Martens, S., Hofmans, S., Declercq, W., Augustyns, K. & Vandenabeele, P. Inhibitors targeting RIPK1\/RIPK3: old and new drugs. Trends Pharmacol. Sci. 41, 209\u2013224 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"82656_CR27","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1074\/jbc.M115.700997","volume":"291","author":"K Moriwaki","year":"2016","unstructured":"Moriwaki, K. & Chan, F. K. M. Regulation of RIPK3- and RHIM-dependent necroptosis by the Proteasome. J. Biol. Chem. 291, 5948\u20135959 (2016).","journal-title":"J. Biol. Chem."},{"key":"82656_CR28","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1055\/s-0042-1751429","volume":"34","author":"M Rivas","year":"2023","unstructured":"Rivas, M. & Gevorgyan, V. Advances in selected heterocyclization methods. Synlett 34, 1554\u20131562 (2023).","journal-title":"Synlett"},{"key":"82656_CR29","doi-asserted-by":"publisher","first-page":"26523","DOI":"10.1039\/C8RA04550J","volume":"8","author":"V Venkateswarlu","year":"2018","unstructured":"Venkateswarlu, V. et al. Direct N-heterocyclization of hydrazines to access styrylated pyrazoles: synthesis of 1,3,5-trisubstituted pyrazoles and dihydropyrazoles. RSC Adv. 8, 26523\u201326527 (2018).","journal-title":"RSC Adv."},{"key":"82656_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","volume":"10","author":"J Dong","year":"2018","unstructured":"Dong, J. et al. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J. Cheminform. 10, 29 (2018).","journal-title":"J. Cheminform"},{"key":"82656_CR31","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1080\/10406638.2022.2112704","volume":"43","author":"EM Eliwa","year":"2023","unstructured":"Eliwa, E. M. et al. Cu(II)-Promoted the Chemical synthesis of New azines-based Naphthalene Scaffold as in vitro potent mushroom tyrosinase inhibitors and evaluation of their antiproliferative activity. Polycycl. Aromat. Compd. 43, 6018\u20136045 (2023).","journal-title":"Polycycl. Aromat. Compd."},{"key":"82656_CR32","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615\u20132623 (2002).","journal-title":"J. Med. Chem."},{"key":"82656_CR33","doi-asserted-by":"publisher","first-page":"12156","DOI":"10.1021\/acs.jmedchem.9b01813","volume":"63","author":"RR Miller","year":"2020","unstructured":"Miller, R. R. et al. Integrating the impact of Lipophilicity on potency and pharmacokinetic parameters enables the Use of Diverse Chemical Space during small Molecule Drug optimization. J. Med. Chem. 63, 12156\u201312170 (2020).","journal-title":"J. Med. Chem."},{"key":"82656_CR34","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.3390\/molecules26144240","volume":"26","author":"MM Arafeh","year":"2021","unstructured":"Arafeh, M. M., Moghadam, E. S., Adham, S. A. I., Stoll, R. & Abdel-Jalil, R. J. Synthesis and cytotoxic activity study of Novel 2-(Aryldiazenyl)-3-methyl-1H-benzo[g]indole derivatives. Molecules 26, 4240 (2021).","journal-title":"Molecules"},{"key":"82656_CR35","first-page":"103","volume":"25","author":"A Barto\u0161ov\u00e1","year":"2017","unstructured":"Barto\u0161ov\u00e1, A., Blinov\u00e1, L., Sirotiak, M. & Michal\u00edkov\u00e1, A. Usage of FTIR-ATR as non-destructive analysis of selected toxic dyes. Res. Pap Fac. Mater. Sci. Technol. Slovak Univ. Technol. 25, 103\u2013111 (2017).","journal-title":"Res. Pap Fac. Mater. Sci. Technol. Slovak Univ. Technol."},{"key":"82656_CR36","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/ajoc.201700609","volume":"7","author":"P Wadhwa","year":"2018","unstructured":"Wadhwa, P., Kharbanda, A. & Sharma, A. Thia-Michael Addition: an emerging strategy in Organic synthesis. Asian J. Org. Chem. 7, 634\u2013661 (2018).","journal-title":"Asian J. Org. Chem."},{"key":"82656_CR37","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bmcl.2018.01.027","volume":"28","author":"S Yakaiah","year":"2018","unstructured":"Yakaiah, S., Sagar Vijay Kumar, P., Baby Rani, P., Durga Prasad, K. & Aparna, P. Design, synthesis and biological evaluation of novel pyrazolo-oxothiazolidine derivatives as antiproliferative agents against human lung cancer cell line A549. Bioorg. Med. Chem. Lett. 28, 630\u2013636 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"82656_CR38","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s00706-018-2292-x","volume":"149","author":"S Asghari","year":"2018","unstructured":"Asghari, S., Pourshab, M. & Mohseni, M. Synthesis, characterization, and evaluation of antioxidant and antibacterial activities of novel indole-hydrazono thiazolidinones. Monatshefte f\u00fcr Chemie - Chem. Mon. 149, 2327\u20132336 (2018).","journal-title":"Monatshefte f\u00fcr Chemie - Chem. Mon"},{"key":"82656_CR39","doi-asserted-by":"publisher","first-page":"9149","DOI":"10.1039\/D3NJ05774G","volume":"48","author":"MM Abdou","year":"2024","unstructured":"Abdou, M. M. et al. Tailoring of novel morpholine-sulphonamide linked thiazole moieties as dual targeting DHFR\/DNA gyrase inhibitors: synthesis, antimicrobial and antibiofilm activities, and DFT with molecular modelling studies. New. J. Chem. 48, 9149\u20139162 (2024).","journal-title":"New. J. Chem."},{"key":"82656_CR40","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1080\/17568919.2024.2342668","volume":"16","author":"WE Elgammal","year":"2024","unstructured":"Elgammal, W. E. et al. Thiazolation of phenylthiosemicarbazone to access new thiazoles: anticancer activity and molecular docking. Future Med. Chem. 16, 1219\u20131237 (2024).","journal-title":"Future Med. Chem."},{"key":"82656_CR41","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00203-020-01923-x","volume":"202","author":"AG Boulis","year":"2020","unstructured":"Boulis, A. G. et al. Diverse bioactive metabolites from Penicillium sp. MMA derived from the red sea: structure identification and biological activity studies. Arch. Microbiol. 202, 1985\u20131996 (2020).","journal-title":"Arch. Microbiol."},{"key":"82656_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/0471142735.im0201s110","volume":"110","author":"V. P. Hornbeck","year":"2015","unstructured":"Hornbeck, V. P. Enzyme-linked immunosorbent assays. Curr. Protoc. Immunol. 110, 211\u20132123 (2015).","journal-title":"Curr. Protoc. Immunol."},{"key":"82656_CR43","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1101\/gad.223321.113","volume":"27","author":"K Moriwaki","year":"2013","unstructured":"Moriwaki, K., Chan, F. & K.-M RIP3: a molecular switch for necrosis and inflammation. Genes Dev. 27, 1640\u20131649 (2013).","journal-title":"Genes Dev."},{"key":"82656_CR44","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1186\/1471-2105-12-S1-S33","volume":"12","author":"KC Hsu","year":"2011","unstructured":"Hsu, K. C., Chen, Y. F., Lin, S. R. & Yang, J. M. iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinform. 12, S33 (2011).","journal-title":"BMC Bioinform."},{"key":"82656_CR45","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/17518253.2021.1981462","volume":"14","author":"EM Eliwa","year":"2021","unstructured":"Eliwa, E. M. et al. Metal-free domino amination-knoevenagel condensation approach to access new coumarins as potent nanomolar inhibitors of VEGFR-2 and EGFR. Green. Chem. Lett. Rev. 14, 578\u2013599 (2021).","journal-title":"Green. Chem. Lett. Rev."}],"updated-by":[{"DOI":"10.1038\/s41598-025-30018-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82656-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82656-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82656-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:03:20Z","timestamp":1764075800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82656-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["82656"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-82656-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-30018-0","URL":"https:\/\/doi.org\/10.1038\/s41598-025-30018-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33340"}}